Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
India
/
Healthcare
/
Krsnaa Diagnostics
KRSNAA
Krsnaa Diagnostics
Government Delays And Cost Pressures Will Challenge Diagnostics Optimistically
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
₹949.00
16.4% undervalued
intrinsic discount
24 Aug
₹793.45
1Y
9.2%
7D
-4.2%
Loading
1Y
9.2%
7D
-4.2%
Author's Valuation
₹949.0
16.4% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
₹949.0
16.4% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-621m
15b
2017
2019
2021
2023
2025
2027
2028
Revenue ₹14.7b
Earnings ₹2.1b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
24.39%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹2.06b
Earnings '28
x
21.14x
PE Ratio '28
=
₹43.50b
Market Cap '28
₹43.50b
Market Cap '28
/
32.41m
No. shares '28
=
₹1.34k
Share Price '28
₹1.34k
Share Price '28
Discounted to 2025 @ 12.73% p.a.
=
₹937.00
Fair Value '25
